Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Great Portland Estates secures pre-let deal for 30 Duke Street

(Sharecast News) - Great Portland Estates announced the securing of a significant pre-let agreement for its flagship development at 30 Duke Street, St James's, SW1 on Wednesday, with global investment firm Clayton, Dubilier & Rice (CD&R) taking the entire 62,500 square feet of office space on a 15-year lease with no break options. The FTSE 250 company said the lease was agreed at rents above its March estimated rental value, and came more than a year ahead of the building's scheduled completion in summer 2026.

It said the building, designed by Make Architects, would feature column-free office floors across eight levels and 3,700 square feet of roof terraces, alongside best-in-class amenities and sustainability credentials.

GPE highlighted the project's pioneering approach to carbon reduction, with 78% of the steel frame sourced from recovered material - mainly from the firm's own City Place House deconstruction - representing the UK's largest known steel reuse scheme and achieving a 90% carbon saving versus new steel.

The early pre-let underscored continued robust demand for premium, sustainable office space in London's West End.

"CD&R is one of the world's leading global investment firms and we are delighted to welcome them to our latest development," said leasing director Marc Wilder.

"This letting is a testament to both the exceptional quality of the design of the building and the continued appeal of St James's as a core destination for the financial sector and we are proud that they have chosen us as their trusted partner to establish their UK headquarters."

At 0901 BST, shares in Great Portland Estates were up 1.24% at 325.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.